Journal article · 2025
HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update
Value in Health, 28(12), S351 · Published 1 December 2025 · DOI 10.1016/j.jval.2025.09.1562
In brief
“HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update” is a 2025 journal article by Maria Manuel Teixeira and 5 co-authors, published in Value in Health. OpenAlex counts 0 citations as of 22 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- Authors
- 6
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Teixeira, M. M., Monteiro, D. M., Borges, F. C., Sepodes, B. M. N., Pe, M. L., & Torre, C. (2025). HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update. Value in Health, 28(12), S351. https://doi.org/10.1016/j.jval.2025.09.1562
MLA 9
Teixeira, Maria Manuel, et al. “HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update.” Value in Health, vol. 28, no. 12, 2025, p. S351. https://doi.org/10.1016/j.jval.2025.09.1562.
Chicago
Teixeira, Maria Manuel, Diogo Manuel Monteiro, Fábio Cardoso Borges, Bruno Miguel Nogueira Sepodes, Madeline Lee Pe, and Carla Torre. 2025. “HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update.” Value in Health 28 (12): S351. https://doi.org/10.1016/j.jval.2025.09.1562.
Harvard
Teixeira, M. M. et al. (2025) ‘HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update’, Value in Health, 28(12), p. S351. doi:10.1016/j.jval.2025.09.1562.
IEEE
M. M. Teixeira, D. M. Monteiro, F. C. Borges, B. M. N. Sepodes, M. L. Pe, and C. Torre, “HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update,” Value in Health, vol. 28, no. 12, p. S351, 2025, doi: 10.1016/j.jval.2025.09.1562.
BibTeX
@article{teixeira2025patient,
title = {{HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update}},
author = {Teixeira, Maria Manuel and Monteiro, Diogo Manuel and Borges, Fábio Cardoso and Sepodes, Bruno Miguel Nogueira and Pe, Madeline Lee and Torre, Carla},
journal = {Value in Health},
year = {2025},
volume = {28},
number = {12},
pages = {S351},
doi = {10.1016/j.jval.2025.09.1562},
url = {https://doi.org/10.1016/j.jval.2025.09.1562}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- patient-reported outcomes
- regulatory approval
- oncology drugs
- European Union
- drug approval decisions
Work with this paper
Most-cited papers in Economics, Econometrics and Finance
- Theory of the firm: Managerial behavior, agency costs and ownership structureMichael C. Jensen, William H. Meckling · Journal of Financial Economics · 1976 · 77,585 citations
- Institutions, Institutional Change and Economic PerformanceDouglass C. North · Cambridge University Press eBooks · 1990 · 34,377 citations
- The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.John E. Ware, Cathy Donald Sherbourne · PubMed · 1992 · 33,943 citations
- Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment EquationsManuel Arellano, Stephen R. Bond · The Review of Economic Studies · 1991 · 33,778 citations
- Co-Integration and Error Correction: Representation, Estimation, and TestingRobert F. Engle, C.W.J. Granger · Econometrica · 1987 · 32,847 citations
Questions about this paper
How do I cite this paper in APA style?
Teixeira, M. M., Monteiro, D. M., Borges, F. C., Sepodes, B. M. N., Pe, M. L., & Torre, C. (2025). HPR155 Patient-Reported Outcomes Used for Regulatory Approval of Oncology Medicinal Products in the European Union Between 2021 and 2024: A Review Update. Value in Health, 28(12), S351. https://doi.org/10.1016/j.jval.2025.09.1562
How many times has this paper been cited?
0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Maria Manuel Teixeira, Diogo Manuel Monteiro, Fábio Cardoso Borges, Bruno Miguel Nogueira Sepodes, Madeline Lee Pe, Carla Torre.
What is the DOI of this paper?
10.1016/j.jval.2025.09.1562, permanently at https://doi.org/10.1016/j.jval.2025.09.1562. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.